U.S. markets close in 2 hours 14 minutes

iCAD, Inc. (ICAD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
16.73-0.59 (-3.41%)
As of 1:45PM EST. Market open.
Sign in to post a message.
  • J
    J
    My initial instincts were not favorable to this move by icad but as jerry noted it appears to have worked out. Perhaps they are using this to thwart a hostile take over or attempted buy on the cheap. This company is going to be worth a whole lot more once GBM trials start signaling positive results. Not to mention reimbursement codes being upgraded maaayyybe in july but more likely next year. I will take $45 in a buyout this year but no way after that. We have under 25 mil shares, cash flow positive within a year and a pristine balance sheet and a razor business getting ready to cut a nice check yoy. Hold tight, it's going to get interesting.
  • J
    John1
    Isn't this kind of a rip on us current shareholders to announce the selling of a million plus shares at $18 for the next two days when the current price is over $20? Why?
    Bullish
  • J
    J
    While I knew shares would turn into an issue I was hopeful relief would come in the form of a 2 for 1 when we hit the mid twenties. You know, reward long term shareholders! Silly me With all the one on one investor meetings there just was'nt enough shares ( for a buyer ) without driving the share price beyond their buy points. Such is the market I suppose, 2 for 1 could still happen but much less likely now.
  • J
    John1
    Very nice Earnings Report especially as we are still under the pandemic specter. 2021, especially with the roll out of the 3D detection system will be a block buster for the company.
    Bullish
  • s
    sea
    Well-timed raise after all. Signal to go up.... buying the future
  • J
    J
    Cowen 41st Annual Health Care Conference,,,,,NEXT!!!
  • J
    J
    Now that skin has returned to positive reimbursement in all states we should see rapid ramping of recurring revenue with models already in place. Klein perhaps offered up a read between the lines here, I do not recall codes being changed for skin so maybe they are lumped in with CPT currently being contested( or not) that may be coming from reimbursements across the board.
  • s
    sea
    No need for a xoft landing anymore? Pre-rsplit we are still only at 3 and change though.
    All time high was like 150 post split...or 300 in real money, 750 corrected for sp500 gain....as it was 33 years ago. Only a x20 or x50 to go then!
  • s
    sanjay
    Time to sell . Make profit
  • J
    James
    HIFU just had a CPT-1 code which is good for the likes of EDAP another of my cancer treatment/cure plays. It only a matter of time before ICAD and brachytherapy comes along. HIFU never had this coding before so its good for all non-incumbent solutions.
  • W
    William
    Share price reacting well... Message board is quiet... I am not at full position and w/the lack of pumpers/bashers its probably still ok to add even w/the run up as of late. I would rather average up than down in my experience. Just my $0.02. GL
  • s
    s_cap
    On October 26, 2018, Dr. Lawrence Howard and Mr. Steven Rappaport each submitted his resignation from the Board of Directors
  • s
    sea
    Well, well finally the best? AI medical software is getting some attention after all? License to Hologic and... boom...
  • s
    sea
    PM boost from....JMP Securities analyst David Turkaly initiated coverage of iCAD with an Outperform rating and $15 price target. The analyst is positive on the company's platform focus of improving detection of early stage cancers, stating its products offer "meaningful benefits to patients, customers, and healthcare providers alike". Turkaly also cites "notable progress" made by iCAD in 2019 under CEO Mike Klein, with the company posting a double-digit, top-line growth driven by the successful commercial launch of its ProFound AI detection produc
  • B
    Bill
    When the 12 year CEO gets "Retired" just a couple days before the scheduled announcement of Q3 earnings, can that be taken as a hint of Q3 numbers not being very good?
  • G
    GERRY
    Congratulations to this management team for their grit and determination. Let's hope that this is just the beginning!
    Bullish
  • s
    sea
    Really positive study on iort Vs standard 30x treatment published in bmj.
  • s
    sea
    Quiet board. quiet quarter. Analysts on the call showed more interest than for years, so it's not a hidden story.
  • s
    s_cap
    New board chair named, two new members appointed after critical letter
    New board chair named, two new members appointed after critical letter
    www.nhbr.com
  • s
    sea
    Well, either it's AI or then its the best kept secret getting out. Success in leading AI maybe worth a 500 m market cap, but if CMS levels the playing field for radiation sky is no limit....